microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis

IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells

(2020) Haiyu Zhang et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

HIF1α‐dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions

(2020) Rafael Contreras‐Lopez et al.   FASEB JOURNAL

Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin

(2019) Chao He et al.   Clinical Epigenetics

The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis

(2019) Liangfeng Chen et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells

(2019) Ali Morovati et al.   MOLECULAR BIOLOGY REPORTS

Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model

(2019) TAKASHI HIGUCHI et al.   ANTICANCER RESEARCH

Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma

(2019) TAKASHI HIGUCHI et al.   ANTICANCER RESEARCH

The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling

(2019) Ling Yu et al.   MOLECULAR CANCER RESEARCH

JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway

(2019) Xinnan Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Marital Status and Survival in Osteosarcoma Patients: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

(2019) Shui Qiu et al.   MEDICAL SCIENCE MONITOR

Prognostic factors for survival among patients with primary bone sarcomas of small bones

(2018) Zhan Wang et al.   Cancer Management and Research

MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1

(2018) Wei Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?

(2017) Gaia Palmini et al.   MOLECULES

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma

(2017) Kuisheng Liu et al.   Cell Death & Disease

lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy

(2017) Xiang Zhou et al.   Cell Death & Disease

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun

(2017) Gang Huang et al.   Oncotarget

HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins

(2017) Lei Sun et al.   Journal of Cancer

SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer

(2016) Z Zhou et al.   ONCOGENE

Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma

(2015) Xiaojiang Li et al.   MEDICAL ONCOLOGY

Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal

(2015) Suoyuan Li et al.   TUMOR BIOLOGY

microRNAs as Developmental Regulators

(2015) Kathryn N. Ivey et al.   Cold Spring Harbor Perspectives in Biology

MicroRNA-24 Regulates Macrophage Behavior and Retards Atherosclerosis

(2014) Karina Di Gregoli et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy

(2014) Juntao Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

(2014) Y Kurokawa et al.   BRITISH JOURNAL OF CANCER

TRAF4 Enhances Osteosarcoma Cell Proliferation and Invasion by Akt Signaling Pathway

(2014) Weitao Yao et al.   ONCOLOGY RESEARCH

HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors

(2013) Deanna D Dailey et al.   BMC Veterinary Research

starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data

(2013) Jun-Hao Li et al.   NUCLEIC ACIDS RESEARCH

miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control

(2012) CHIARA NOVELLO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

G9a Histone Methyltransferase Activity in Retinal Progenitors Is Essential for Proper Differentiation and Survival of Mouse Retinal Cells

(2012) K. Katoh et al.   JOURNAL OF NEUROSCIENCE

Expression and stability of hypoxia inducible factor 1α in osteosarcoma

(2012) Amal El Naggar et al.   PEDIATRIC BLOOD & CANCER

Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression

(2012) W. Luo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HMGB1 Promotes Drug Resistance in Osteosarcoma

(2011) J. Huang et al.   CANCER RESEARCH

Analysis of rpoS and bolA gene expression under various stress-induced environments in planktonic and biofilm phase using 2−ΔΔCT method

(2011) Mohd Adnan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Therapy for Osteosarcoma

(2008) Alexander J Chou et al.   PEDIATRIC DRUGS